Metformin Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition
Metformin Hydrochloride Price Trend, Index and Forecast
Track the latest insights on metformin hydrochloride price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Metformin Hydrochloride Prices Outlook Q1 2026
- South Korea: 4066 USD/MT
- China: 3579 USD/MT
- Germany: 4144 USD/MT
- India: 3731 USD/MT
- France: 4583 USD/MT
Metformin Hydrochloride Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the first quarter of 2026, the metformin hydrochloride prices in South Korea reached 4066 USD/MT in March. Prices exhibited a steady upward trajectory, influenced by improved domestic supply chain efficiency and moderate recovery in local demand. Import regulations and raw material availability played a stabilizing role, while international pharmaceutical demand contributed to cautious price increases. Market participants noted controlled production levels by local manufacturers, which tempered volatility.
During the first quarter of 2026, the metformin hydrochloride prices in China reached 3579 USD/MT in March. Domestic production was supported by a consistent raw material supply, leading to stable but slightly increasing prices. Policy measures encouraging pharmaceutical exports created moderate demand pressure. Transportation and logistics improvements reduced delays, supporting smoother distribution.
During the first quarter of 2026, the metformin hydrochloride prices in Germany reached 4144 USD/MT in March. The increase was driven by consistent industrial demand and efficient domestic supply chains. Raw material availability remained stable, while energy and labor costs contributed marginally to price adjustments. Regulatory compliance costs and quality control measures influenced production pricing.
During the first quarter of 2026, the metformin hydrochloride prices in India reached 3731 USD/MT in March. Prices edged upward, supported by consistent domestic demand and controlled production adjustments. Raw material supply was largely stable, mitigating price volatility. Export opportunities into neighboring regions provided additional market support. Transport efficiency and regional manufacturing coordination helped maintain smooth operations.
During the first quarter of 2026, the metformin hydrochloride prices in France reached 4583 USD/MT in March. Prices moved upward due to steady industrial demand and supply chain stability. Regulatory compliance costs and raw material sourcing affected production pricing. Regional pharmaceutical demand remained strong, supporting moderate price increases. Operational efficiencies, including logistics and energy management, contributed to consistent pricing.
Metformin Hydrochloride Prices Outlook Q2 2025
- USA: USD 4420/MT
- China: USD 3540/MT
- Germany: USD 4330/MT
- India: USD 3740/MT
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing metformin hydrochloride prices.
Europe Metformin Hydrochloride Price Trend
Q1 2026:
The metformin hydrochloride price index showed gradual upward movement. Regional manufacturing was stable, supported by steady raw material supply. Export activity increased moderately, influencing pricing dynamics. Regulatory compliance and quality standards maintained moderate production costs. Transport efficiency across borders supported distribution. Seasonal demand patterns encouraged incremental price increases. Supply chain coordination mitigated volatility, and overall pricing remained cautiously positive.
This analysis can be extended to include detailed metformin hydrochloride price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Metformin Hydrochloride Price Trend
Q1 2026:
The metformin hydrochloride price index in North America experienced varied trends in Q1 2026. Domestic production was consistent with industry forecasts, while raw material availability remained stable. Distribution channels operated efficiently, supporting price stability. Increased regional pharmaceutical consumption created moderate upward pressure. Inventory levels were managed effectively, avoiding sudden surges or drops. Operational cost management supported incremental price growth. Market sentiment remained optimistic, reflecting balanced supply and demand.
Specific metformin hydrochloride historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Metformin Hydrochloride Price Trend
Q1 2026:
According to the price chart for metformin hydrochloride, supply chain interruptions, seasonal changes in demand, and geopolitical influences were the main causes of the price fluctuations in the Middle East and Africa.
In addition to region-wise data, information on metformin hydrochloride prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Metformin Hydrochloride Price Trend
Q1 2026:
Metformin hydrochloride prices in the Asia Pacific increased moderately. Strong domestic demand from pharmaceutical sectors supported incremental price growth. Production efficiencies and supply chain improvements balanced upward pressure. Export opportunities and regional trade agreements encouraged gradual market expansion. Transportation stability and inventory management helped maintain consistent pricing. Market participants adopted cautious pricing approaches to align with demand patterns. Overall, upward trends reflected balanced supply-demand dynamics.
This metformin hydrochloride price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Metformin Hydrochloride Price Trend
Q1 2026:
A thorough overview is given by the analysis of metformin hydrochloride prices in Latin America, which reflects the distinct market dynamics in the area impacted by trade frameworks, industrial expansion, and economic policies.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Metformin Hydrochloride Pricing Report, Market Analysis, and News
IMARC's latest publication, “Metformin Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the metformin hydrochloride market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of metformin hydrochloride at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed metformin hydrochloride prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting metformin hydrochloride pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Metformin Hydrochloride Industry Analysis
The global metformin hydrochloride market size reached USD 313.0 Million in 2025. By 2034, IMARC Group expects the market to reach USD 487.1 Million, at a projected CAGR of 4.89% during 2026-2034. The market is primarily driven by the rising global demand for diabetes treatment, expansion of pharmaceutical manufacturing capacities, and increased government and private sector healthcare initiatives.
Latest News and Developments:
- June 2026: Apotex Corp. announced the US launch of sitagliptin tablets and sitagliptin and metformin hydrochloride tablets, both qualifying for 180 day shared exclusivity. The launches strengthened the company's portfolio of therapies for adults with type 2 diabetes mellitus, a condition affecting millions across the United States. Sitagliptin tablets are AB rated to Merck's JANUVIA® and are approved as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes. The introduction is expected to improve patient access to affordable diabetes treatment options.
- February 2024: IOL Chemicals & Pharmaceuticals declared that its product metformin hydrochloride has been approved by the Center for Drug Evaluation (CDE) of National Medical Products Administration (NMPA). This will enable the company to export metformin hydrochloride in China market.
- March 2024: Theon Pharma announced the launch of a combination drug like linagliptin, dapagliflozin, and metformin hydrochloride (SR). The combination is indicated in adults with type 2 diabetes mellitus (T2DM).
Product Description
Metformin hydrochloride is a widely used oral antihyperglycemic agent primarily prescribed for type 2 diabetes management. Chemically, it is a biguanide derivative, consisting of two linked guanidine groups. It exhibits high water solubility, stability under standard storage conditions, and favorable pharmacokinetic properties. Industrially, it is produced through controlled chemical synthesis, often involving cyanoguanidine and other intermediates, followed by purification and crystallization. Metformin hydrochloride finds application in tablet, extended-release, and combination drug formulations. Its properties, including effective glucose regulation and minimal risk of hypoglycemia, make it a core component in therapeutic protocols. Additionally, it supports research into metabolic diseases and serves as a standard reference in pharmaceutical quality control. Its scalability and cost-effectiveness ensure broad industrial utilization across global markets.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Metformin Hydrochloride |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Metformin Hydrochloride Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of metformin hydrochloride pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting metformin hydrochloride price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The metformin hydrochloride price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: [email protected]
Client Testimonials
.webp)
.webp){kind=logo}
Related Reports
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.